A one-stop-shop CRO bringing together innovative platforms, strategic solutions and specialized expertise to drive drug development and advance diverse fields of research.
Policies, Terms & Conditions
04.15.24
Huningue, France – Firalis Molecular Precision (FMP), a CAP-accredited fast-growing Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), announces its upcoming participation in Swiss Biotech Day 2024, taking place in Basel, Switzerland, from April 22nd to April 23rd.
Swiss Biotech Day serves as a valuable platform for networking and collaboration in the life sciences community. With over 1,800 experts expected to attend, this year’s event promises fruitful discussions and partnerships. FMP’s experts are eager to connect with peers, startups, and mid-sized biotech firms to share insights, partner and drive innovation together.
FMP will use the event’s “Global Village” to strengthen its connections with Switzerland as a thriving biotech hub.
“We’re excited to be part of Swiss Biotech Day and to collaborate with industry leaders to drive innovation in healthcare and precision medicine,” said FMP’s CEO, David Halter. “This event is a golden opportunity to showcase our expertise in multi-omics and bioanalytical laboratory services, build partnerships, and advance life sciences worldwide.”
FMP invites all attendees to schedule a one-to-one partnering meeting with its expert Business Developers at Swiss Biotech Day 2024 and join the conversation through this link : precursion-biosciences.com/contact-us
About Firalis Molecular Precision
Firalis Molecular Precision (FMP) is a fast-growing CRO & CDMO, providing advanced multi-omics solutions and tailored contract research services to the Life Sciences sector.
With headquarters in Huningue, France, and a presence in Cambridge, Mass., FMP is renowned for its commitment to innovation and excellence.
Leveraging cutting-edge technologies, FMP offers a comprehensive suite of bioanalytical services encompassing biobanking, multiomics-driven analyses (including genomics, proteomics, transcriptomics, lipidomics, and metabolomics), as well as omic data analysis, assay development, and custom in vitro diagnostic (IVD) kit manufacturing.
FMP’s mission is to empower healthcare professionals, researchers, and biopharmaceutical entities with the tools and solutions they need to drive progress towards better patient care and a more personalized medicine.
Share this article on your socials